ARTICLE | Clinical News
Pimagedine: Began a Phase II/III trial in 660 patients
February 22, 1994 8:00 AM UTC
Alteon Inc. (ALTN), Northvale, N.J. Product: Pimagedine (formerly aminoguanidine) Indication: Diabetic patients who have shown progression of kidney disease Status: Began a Phase II/III trial in 660 p...